NDC 10157-9409 - Blistex Baby Kanka
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 10157-9409
- Package NDCs from labels
- 10157-9409-1
- Manufacturer
- Blistex Inc.
- Effective date
- 2015-01-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Blistex Baby Kanka ® Gel | Blistex Inc. | 2015-01-22 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10157-9409-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-dd11-f424-e053-dadaa90a57ce | Blistex Baby Kanka ® Gel |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9409-1 | Blistex Baby Kanka | 10 g in 1 TUBE | GEL | 10 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9409 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | 1 package rows | 20150129_b70ff808-43d3-4a14-867e-b56f9db9da87.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Benzocaine | ACTIVE INGREDIENT | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| Benzocaine | ACTIVE MOIETY | U3RSY48JW5 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | BLISTEX BABY KANKA (BENZOCAINE) GEL [BLISTEX INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4x Medicated Toothache and Gum Cream | BENZOCAINE | CVS | a7576238-e7c8-7e86-e053-2995a90aaeb5 | 2026-04-20 | Warnings | U3RSY48JW5 |
| CVS Pharmacy Maximum Strength | BENZOCAINE | CVS Pharmacy | 92747826-cf58-4406-b3b5-12f7c7077c2c | 2026-04-20 | Warnings | U3RSY48JW5 |
| Benzodent | BENZOCAINE | Focus Consumer Healthcare, LLC | 5fdcb871-d387-6352-e053-2991aa0a09da | 2026-04-20 | Warnings | U3RSY48JW5 |
| Sting Relief Swab | BENZOCAINE | 4 Visions LLC | 4fc7a356-2f1d-85af-e063-6394a90aec6b | 2026-04-18 | Warnings | U3RSY48JW5 |
| Coleman Bite and Sting Relief | EXTERNAL ANESTHETIC AND FIRST AID ANTISEPTIC | Wisconsin Pharmacal Company | 4fadf1f1-478a-5104-e063-6294a90a10cb | 2026-04-17 | Warnings | U3RSY48JW5 |
| Coleman Sting and Bite Relief | EXTERNAL ANALGESIC AND FIRST AID ANTISEPTIC | Wisconsin Pharmacal Company | 4f94ab35-3099-716c-e063-6294a90a8bea | 2026-04-16 | Warnings | U3RSY48JW5 |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | G2M7P15E5P |
| BiteMD | INSECT BITE RELIEF | Wisconsin Pharmacal Company | 4f860c1e-a638-4923-e063-6294a90ae7e2 | 2026-04-15 | Warnings | U3RSY48JW5 |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | G2M7P15E5P |
| PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | 4e442a72-b13b-4869-8a1d-59356095b091 | 2026-04-14 | Warnings, Adverse reactions | G2M7P15E5P |
| Sting Relief Swab | BENZOCAINE | 4 Visions LLC | 4f76a8c5-fde6-eee0-e063-6394a90a09f8 | 2026-04-14 | Warnings | U3RSY48JW5 |
| Artificial Tears Lubricant Eye Drops | GLYCERIN, PROPYLENE GLYCOL | CVS Pharmacy | 28297fee-8185-4869-8f39-5bfbf8bf8bfd | 2026-04-13 | Warnings | PDC6A3C0OX |
| blink boost | GLYCERIN | Bausch & Lomb Incorporated | e765c224-1718-488f-99b2-976eb60c1d63 | 2026-04-13 | Warnings | PDC6A3C0OX |
| Retaine Ultra PF | POLYETHYLENE GLYCOL | OCuSOFT LLC | a5aaaf06-772d-44d3-8601-f978ddc48ad7 | 2026-04-13 | Warnings | B697894SGQ |
| clear lax | POLYETHYLENE GLYCOL 3350 | Meijer Distribution Inc | 6464f12c-0883-46c5-943b-a84fe235588e | 2026-04-13 | Warnings | G2M7P15E5P |
| Hemorrhoidal Cream with Lidocaine | GLYCEROL, PHENYLEPHINE, PRAMOXINE, PETROLATUM | Trifecta Pharmaceuticals Usa Llc | 4f1ef866-c4af-989b-e063-6294a90a148e | 2026-04-10 | Warnings | PDC6A3C0OX |
| WE FRESH Lubricating Eye Drops | GLYCERIN | Oculus Surgical, Inc. | 4f253b5d-001b-091e-e063-6394a90a9d39 | 2026-04-09 | Warnings | PDC6A3C0OX |
| Sore Throat | PHENOL GLYCERIN | Walgreens | 1e845299-178e-49ce-9d08-7e9d548a5a6d | 2026-04-09 | Warnings | PDC6A3C0OX |
| Thera Plus Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HYDROCHLORIDE, PRAMOXINE HYDROCHLORIDE, WHITE PETROLATUM | Fourstar Group USA, Inc. | 5d63bf97-29d2-4c71-97c3-85f425e86207 | 2026-04-07 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.